President, CEO, Co-founder
Research & Development
Field Application Support
Research & Development
BioSkryb Services Group
New Product Introduction
Primary Template-directed Amplification (PTA) is a novel and accurate whole-genome amplification (WGA) method for the genomic analysis of single cells. Here we demonstrate the importance of understanding the heterogeneity of genomic modifications that occur between individual cells within a cancer specimen.
BioSkryb Genomics has developed a variety of integrated single-cell workflows to enable cell isolation and enrichment. The dissection of cellular heterogeneity depends on the ability to differentiate the omic layers that define an individual cell. Single cell tissue heterogeneity drives cellular evolution in both development and disease (Figure 1). In this case tumor invasion is dictated by multiple effectors within the genome, transcriptome and expressed proteins. Applications and methods developed and reported here utilize several different systems and platforms which enable a wide range of cell acquisition techniques that are compatible with downstream single cell omic analysis. Downstream omic analysis supported by BioSkryb Genomics application systems, include whole genome and whole mRNA transcriptome sequencing, as well as targeted surface protein analysis. In addition, the open platforms allow the user to develop and make use of a wide array of published chemistry platforms. We summarize here the various methods, all having individual strengths and shortcomings.
Platforms utilized upstream of omic analysis
Sony SH800 FACS Enrichment
NanoCellect WOLF FACS enrichment
ALS Jena - CellCelector
Downstream chemistry workflows
ResolveDNA WGA - Single Cell Genome
ResolveRNA RNAseq - Single Cell Transcriptome
ResolveOME - Single Cell Multiomics
Genome (WGS, WES, Panel)
Transcriptome (Full-length mRNA transcript)
Integratable with surface marker proteins*
User-defined single cell chemistries
BioSkryb BaseJumper compatibilities
Cloud-based Omic data intrepration
Risk-based analysis using ClinVar/Cosmic
Cellular Heterogeneity drives normal development and disease(Figure 1), through a myriad of intracellular macromolecular factors1. At the foundation of these omic layers is the genome of each individual cell. The clonality of cell populations and their phenotypic behavior are influenced, if not dictated by, variation in the genomic structure. Cellular behavior is further influenced by extracellular effectors that may influence gene expression. Our understanding of the complexities of the molecular biology that influence normal development and disease remain immature. The recent broad expansion of both single cell molecular biology approaches, in addition to next generation sequencing (NGS) technologies are allowing a new era of discovery. However, to enable the analysis of each cell or clone, cells must be isolated as individuals. While several single cell platforms have enabled single cell transcriptomics2, and panel based genetic analysis3, the systems are inherently limited to the commercial applications provided by the supplier. Given the massive expansion in methodologies, many users seek open
systems to implement customized molecular biology methods. The use of open isolation and enrichment platforms that provide application flexibility are beneficial to the single-cell user base.
In addition, while higher throughput experiments are highly valuable for discerning differences between phenotypically variable populations, disease states are most frequently driven by clones of low abundance. Often the specific populations of target cells wishing to be studied are either in low percentage or the total number of cells in the specimen, as with clinical samples, are discrete and limited. Such analyses are not compatible with most droplet or microfluidic based systems. The reality is all systems have their strengths and shortcomings.
At Bioskryb Genomics we differentiate by developing the most comprehensive modal analysis to enable broad and accurate product solutions to determine the structure and function driving the biology of each cell. We have further integrated these chemistry systems with upstream cell isolation and enrichment systems (Figure 2) to maximize flexibility for the unique questions posed by researchers and clinicians. These
open single-cell platforms (Figure 2) enable significantly greater breadth and depth in cellular and molecular analysis. Compared to the droplet based systems, which have higher cell throughput with limited dimensional analysis (i.e. 3' end counting or a small gene panel), the open systems provide higher throughput in terms of enrichment and allow the user to focus on a target group of cells with greater breadth and depth within the genome, transcriptome and protein analysis. A key feature of BioSkryb Genomics workflows is the application independence we support.
Initial PTA-based WGA methods were developed in combination with Fluorescent Activated Cell Sorting(FACS)4. Where cell enrichment is a critical experimental requirement, we have developed workflows for both the Sony SH8005 and NanoCellect WOLF6 cell sorting systems (Figure 3). Certain applications, such as the analysis of Minimal Residual Disease (MRD) in cancer require significant cell enrichment. In some cases this requires isolating as few as 1 target cell/1 million nontarget cells (1x106 cells)7. Both systems enable index sorting for quantitative assessment of fluorescent gating at the individual cell level. The WOLF sorter has greater ease of use. In contrast, the SH800 provides greater flexibility in fluorescent markers for surface protein detection. Both instruments are compatible with BioSkryb Genomics products and open source chemistry systems.
Perhaps the most capable of systems is the ALS Jena CellCelector. The CellCelector was designed for single cell studies (Figure 3). Through a combination of high-resolution optics and precise robotics, the instrument has a wide range of capability in the single-cell application sector. Due to the ability to interrogate cells in a sample specimen optically using the array of available consumables, the combination of the CellCelector with the BioSkryb Genomics omic platforms allows the delineation of a broad array of molecular biology layers.
The CellCelector allows a high degree of population enrichment and a broad range of cell inputs, from just a few cells (< 100) to hundreds of thousands of inputed cells. It accomplishes this through the use of magnetic or optical enrichment or a combination of both. The user is then able to detect and differentiate the cells of interest, and select only those most important for downstream BioSkryb genomic, transcriptomic or protein analysis via NGS. Moreover, we are currently developing methods to enable the isolation and enrichment of specific cells from intact tissue sections. This enables spatial context and precision genomics within the context of an organized tissue sample specimen. Similar to the other platforms described, cells enriched by the CellCelector can be used in a myriad of downstream open source single-cell molecular biology and cloning methods.
The single cell field has advanced with breathtaking pace. In particular, the expansion of high-throughput droplet-based RNAseq methods have elucidated the amazing diversity within tissues. However, the lens we use to determine this diversity is currently limited to end fragments of genes that are expressed or to a handful of genomic targets. In order to understand the complexity of biological function, a new approach is needed. The emergence of multi-parameter single-cell analysis is a step to solving this amazing complexity. As with the diversity of cells, our methodologies for understanding the molecular basis of cellular function must evolve. The development of the comprehensive omic ResolveDNA WGA and ResolveOME unified transcriptomic and genomic analysis platforms extend this capability. Key to realizing the impact of these chemistry systems is the ability to synergize with platforms developed to isolate and enrich for target cells that are key to deciphering the biological question.
As described, there are a plethora of cell isolation and enrichment technologies available to the single-cell user today. To enable the greatest flexibility for the downstream user we have developed several example workflows to address a myriad of user needs. A central theme exists however, heterogeneity of tissue cells dictate the fate of the organism. This is true in both normal development, in the progression of disease, and the discovery of new and novel therapeutics. The integration of the BioSkryb Genomics comprehensive molecular omic platforms with these cell isolation and enrichment systems allows a new
direction for the single cell researcher. Discovery is the ability to see something new for the first time. To facilitate this discovery, extending our methodologies beyond the existing systems is required.
Currently, genome-based analysis of single cells is limited by NGS sequencing throughput and cost. This is particularly true when sequencing whole genomes of single cells for SNV analysis. As an example, using the Illumina NovaSeq 6000, currently it is possible to sequence 30-40 single cells for comprehensive SNV calling. However, utilizing genome enrichment methods, either Whole Exome Sequencing (WES) or large targeted panels (~6700 genes) increases cellular throughput to several hundred to thousands of cells/flowcell sequencing run8. This flexibility in genome fraction analysis is critical as discovery depends on broad genome coverage of a wide array of implicated genes in various developmental pathways. Similar to increase in throughput of RNAseq methods, which was enabled by decreasing sequencing cost9, we anticipate an ever growing need to increase cellular throughput for DNA analysis. As sequencing cost decreases, a proportional increase in comprehensive omic analysis will increase. The data will be evermore complex.
To interpret and understand such multi-faceted data sets, new data analysis tools will be required. For the ResolveDNA, ResolveOME and ResolveDNA Microbiome products this requires integration to the cloud-based analytics system BaseJumper(Figure 4). BaseJumper standardizes user views to focus on the discovery, while enabling flexible and user customized data analysis. The ability to interpret these complex data sets is, in the end, the most critical step in driving to impactful insights that can alter the course of disease in a broad array of application sectors including, oncology, neurology, reproductive health, immunology and influence of the microbiome on our environment and our health.
- Kashima, Y., et al., Single-cell sequencing techniques from individual to multiomics analyses. Exp Mol Med, 2020. 52(9): p. 1419-1427.
- See, P., et al., A Single-Cell Sequencing Guide for Immunologists. Front Immunol, 2018. 9: p. 2425.
- Pellegrino, M., et al., High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics. Genome Res, 2018. 28(9): p. 1345-1352.
- Gonzalez-Pena, V., et al., Accurate genomic variant detection in single cells with primary template-directed amplification. Proc Natl Acad Sci U S A, 2021. 118(24).
- Zawistowski, J., BioSkryb Cell Sorting Protocol for live cell sorting with minimal dropouts, in www.bioskryb.com, B. Genomics, Editor. 2021, BioSkryb Genomics. p. 5.
- Zawistowski, J. and A. Krasny, Pairing Uniform WholeGenome Amplification with Simple Single-cell Sorting. 2021, BioSkryb Genomics: www.bioskryb.com. p. 4.
- Sherrod, A.M., et al., Minimal residual disease testing after stem cell transplantation for multiple myeloma. Bone Marrow Transplant, 2016. 51(1): p. 2-12.
- Zawistowski, J., et al., ResolveDNA Integration with Illumina DNA Prep and DNA Prep with Enrichment to Enable Singlecell Genomics. 2022, BioSkryb Genomics. p. 1-5.
- Pollen, A.A., et al., Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex. Nat Biotechnol, 2014. 32(10): p. 1053-8.
Download PDF Version
For more information or technical assistance: email@example.com